ICU Medical Q1 GAAP EPS $(1.63) loss, revenue flat at $566.7M

ICU MEDICAL INC/DE

2024-Q1 EPS reported -$1.63 revenue$566,655,000

Revenue $566.7M, down slightly from $568.6M YoY; GAAP net loss $(39.5)M vs $(9.8)M.
GAAP diluted EPS loss $(1.63) compared to loss $(0.41) in prior year.
Adjusted diluted EPS $0.96, down from $1.74; Adjusted EBITDA $78.8M vs $102.0M.
No forward guidance provided in the release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.